Hanmi Science한미사이언스
008930 · KOSPI · ₩008930 · 한미사이언스
Valuation model · Sum of the parts (net asset value)
This is a holding company, so we value what it owns: its stakes in listed companies at market value, less a holding company discount.
Fair value per share
₩20,272
vs the current price (₩43,100)
- Assets before discount
- ₩2.3T
- Equity value
- ₩1.4T
Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal. This is not financial advice.
Bear / Base / Bull
- Bear
- ₩13,515
- −68.6%
- Base
- ₩20,272
- −53.0%
- Bull
- ₩28,381
- −34.1%
Bear: listed stakes 20% lower and a discount 10 points wider. Bull: the opposite.
Assumptions
Sign in to change the assumptions and see the results update. Sign in
Business
- 0%
Moves the market value of the listed companies it owns up or down.
Default: 0, today's market values.
- ₩0B
Anything else it owns, minus its own debt, in ₩ billions.
Default: 0. Unlisted holdings and the company's own cash and debt aren't included unless you add them.
Discount rate
- 40%
How far below the value of its holdings the company is valued.
Default: a typical discount for Korean holding companies.
Starting point
- Shares
- 68,391,550
- Share price
- ₩43,100
- Market cap
- ₩2.9T
Listed stakes
| Company | Stake | Market value |
|---|---|---|
| Hanmi Pharm | 41.4% | ₩2.2T |
| Jvmco | 39.2% | ₩110B |
Sensitivity
Fair value per share as two inputs change; the middle is the current case.
| Listed stakes ↓ · Discount → | 20.0% | 30.0% | 40.0% | 50.0% | 60.0% |
|---|---|---|---|---|---|
| −20.0% | ₩21,624 | ₩18,921 | ₩16,218 | ₩13,515 | ₩10,812 |
| −10.0% | ₩24,327 | ₩21,286 | ₩18,245 | ₩15,204 | ₩12,163 |
| 0.0% | ₩27,030 | ₩23,651 | ₩20,272 | ₩16,894 | ₩13,515 |
| +10.0% | ₩29,733 | ₩26,016 | ₩22,300 | ₩18,583 | ₩14,866 |
| +20.0% | ₩32,436 | ₩28,381 | ₩24,327 | ₩20,272 | ₩16,218 |
Now (TTM)
- Market cap
- ₩2.9T
- Enterprise value
- ₩3T
- P/E
- 19.5×
- P/B
- 2.8×
- P/S
- 2.1×
- EV/EBITDA
- 17.3×
- Dividend yield
- 0.7%
Over time (at each year end)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Price | ₩36,250 | ₩29,450 | ₩39,200 | ₩32,450 | ₩54,200 |
| Market cap | ₩2.5T | ₩2T | ₩2.7T | ₩2.2T | ₩3.7T |
| P/E | 20.9× | 33.9× | 23.3× | 32.1× | 86.3× |
| P/B | 2.6× | 2.4× | 3.4× | 3.1× | 5.4× |
| P/S | 1.8× | 1.6× | 2.1× | 2.1× | 3.9× |
| EV/EBITDA | 17.8× | 20.5× | 22.0× | 33.7× | 60.3× |
| Dividend yield | 0.8% | 1.0% | — | — | — |
Versus similar companies
| Company | P/E | P/B | P/S | EV/EBITDA | Dividend yield |
|---|---|---|---|---|---|
| Hanmi Science | 19.5× | 2.8× | 2.1× | 17.3× | 0.7% |
| SK Square | 3.6× | 2.2× | 96.1× | 3.5× | 0.0% |
| KB Financial Group | 8.8× | 0.9× | — | 9.6× | 2.8% |
| Shinhan Financial Group | 7.8× | 0.7× | — | 10.2× | 2.9% |
| SK | 4.5× | 1.0× | 0.3× | — | 1.6% |
| Hana Financial Group | 8.0× | 0.7× | — | 10.0× | 3.4% |
| Woori Financial Group | 7.1× | 0.6× | — | 8.5× | 4.4% |
| Similar companies (median) | 7.5× | 0.8× | 48.2× | 9.6× | 2.8% |
Calculated from end-of-day prices and filed financial statements. Not a recommendation. This is not financial advice.
Also known as: Hanmi Science / 한미사이언스 / 008930 / KRX:008930
Source: KRX statistical information